More importantly, this work provides evidences that tamoxifen alone has no impact on the growth of ERα-negative tumors, but that it antagonizes E2-induced tumor growth by inhibiting angiogenesis in parallel to vessel normalization. This evidence concerns the gene ERAL1 and neoplasm.